Cases & Deals

  • Home
  • Practices
  • Anteris Technologies completes $25.2 million private placement of Common Stock, CDIs, and accompanying Common Stock Warrants and CDI Warrants

Share

Anteris Technologies completes $25.2 million private placement of Common Stock, CDIs, and accompanying Common Stock Warrants and CDI Warrants

November 2025

Client(s) Anteris Technologies Global Corp.

Jones Day represented Anteris Technologies Global Corp. (NASDAQ: AVR; ASX: AVR) ("Anteris") in connection with a private placement of (i) 2,346,936 shares of its Common Stock and accompanying Common Stock Warrants to purchase an aggregate of 2,346,936 shares of Common Stock and (ii) 2,788,064 of its CHESS Depositary Interests ("CDIs") and accompanying CDI Warrants to purchase an aggregate of 2,788,064 CDIs to various investors in the United States and Australia for an aggregate purchase price of approximately $25.2 million.

Anteris is a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA. Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.